Product Information
POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by Actavis Pharma, Inc., priced at $0.1804 per EA under NDC 00591274201. Its NADAC has been published 425 times since Jul 4, 2018.
FDA first approved this application on Mar 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 meq/1
Manufacturer
Actavis Pharma, Inc.NDC
00591274201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209758FDA Approved
3/5/2018
TE Code
AB
On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 425 times since Jul 4, 2018, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1804 per EA |
|---|---|
| All-time high | $1.6161 (Dec 12, 2018) |
| All-time low | $0.1722 (Jul 17, 2024) |
| 52-week high | $0.2197 |
| 52-week low | $0.1796 |
| Median price | $0.5716 |
| Average price | $0.6890 |
| Largest weekly change | +69.2% (May 17, 2023) |
| Weeks tracked | 425 |
| Tracking since | Jul 4, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by Actavis Pharma, Inc., is $0.1804 per EA (NDC 00591274201), effective Aug 19, 2026.
How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 87.9%. It has been tracked across 425 weekly CMS publications since Jul 4, 2018.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?
Since Jul 4, 2018, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.6161 (Dec 12, 2018), with a median of $0.5716 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?
POTASSIUM CITRATE ER 15 MEQ TB (NDC 00591274201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.